Literature DB >> 8820352

Bacterial behaviour in middle ear effusion material: an in vitro study.

K Ruhani1, S Raisanen, G S Simonsen, L E Stenfors.   

Abstract

Known numbers (CFU/ml) of middle ear pathogens (S. pneumoniae, H. influenzae, M. catarrhalis, S. aureus and beta-haemolytic streptococci group A) and non-pathogens (alpha-haemolytic S. mitis) were inoculated into one end of a micropipet containing a 35 mm long pillar of culture-negative middle ear effusion. The micropipets with the effusion/bacterial suspension were incubated at 37 degrees C and kept at various inclinations to the horizontal plane (15 degrees, 30 degrees and -75 degrees). All S. aureus, M. catarrhalis, alpha- and beta-haemolytic streptococci isolates examined survived in this medium for 18 h. The majority of alpha- and beta-haemolytic streptococci isolates penetrated the MEE, irrespective of the inclination of the micropipet, whereas the number of S. pneumoniae (p<0.01) and H. influenzae (p = NS) isolates penetrating the substrate increased when the micropipets were inclined at -75 degrees to the horizontal. None of the S. aureus and M. catarrhalis isolates penetrated the MEE pillar during the incubation. The present in vitro study demonstrated that MEE possesses an antibacterial property and is able to selectively hinder bacterial penetration.

Entities:  

Mesh:

Year:  1996        PMID: 8820352     DOI: 10.3109/00016489609137714

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  2 in total

1.  Incidence of Helicobacter pylori infection and their clarithromycin-resistant strains in otitis media with effusion regarding phenotypic and genotypic studies.

Authors:  Nahla A Melake; Ghada H Shaker; Magdy A Salama
Journal:  Saudi Pharm J       Date:  2012-03-03       Impact factor: 4.330

2.  Initial events in the pathogenesis of acute tonsillitis caused by Streptococcus pyogenes.

Authors:  M Lilja; S Räisänen; L E Stenfors
Journal:  Int J Pediatr Otorhinolaryngol       Date:  1998-09-15       Impact factor: 1.675

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.